These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 37464416)

  • 1. Aged mesenchymal stem cells and inflammation: from pathology to potential therapeutic strategies.
    Yang X; Wang Y; Rovella V; Candi E; Jia W; Bernassola F; Bove P; Piacentini M; Scimeca M; Sica G; Tisone G; Mauriello A; Wei L; Melino G; Shi Y
    Biol Direct; 2023 Jul; 18(1):40. PubMed ID: 37464416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Potential of Amniotic Fluid Derived Mesenchymal Stem Cells Based on their Differentiation Capacity and Immunomodulatory Properties.
    Harrell CR; Gazdic M; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
    Curr Stem Cell Res Ther; 2019; 14(4):327-336. PubMed ID: 30806325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iberian pig mesenchymal stem/stromal cells from dermal skin, abdominal and subcutaneous adipose tissues, and peripheral blood: in vitro characterization and migratory properties in inflammation.
    Calle A; Barrajón-Masa C; Gómez-Fidalgo E; Martín-Lluch M; Cruz-Vigo P; Sánchez-Sánchez R; Ramírez MÁ
    Stem Cell Res Ther; 2018 Jul; 9(1):178. PubMed ID: 29973295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stem Cell Therapy for Oral Inflammatory Diseases: Research Progress and Future Perspectives.
    Gong W; Wang F; He Y; Zeng X; Zhang D; Chen Q
    Curr Stem Cell Res Ther; 2021; 16(2):165-174. PubMed ID: 32713335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives.
    Regmi S; Pathak S; Kim JO; Yong CS; Jeong JH
    Eur J Cell Biol; 2019 Dec; 98(5-8):151041. PubMed ID: 31023504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-Conditioned Mesenchymal Stem Cells in Tissue Regeneration Application.
    Yang Y; Lee EH; Yang Z
    Tissue Eng Part B Rev; 2022 Oct; 28(5):966-977. PubMed ID: 34569290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological Aspects and Clinical Applications of Mesenchymal Stem Cells: Key Features You Need to be Aware of.
    Saeedi M; Nezhad MS; Mehranfar F; Golpour M; Esakandari MA; Rashmeie Z; Ghorbani M; Nasimi F; Hoseinian SN
    Curr Pharm Biotechnol; 2021; 22(2):200-215. PubMed ID: 32895040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on mesenchymal stem cells: tissue repair, immune modulation, and tumor homing.
    Hong HS; Kim YH; Son Y
    Arch Pharm Res; 2012 Feb; 35(2):201-11. PubMed ID: 22370775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease.
    Yuan M; Hu X; Yao L; Jiang Y; Li L
    Stem Cell Res Ther; 2022 May; 13(1):179. PubMed ID: 35505419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells: Biological characteristics and application in disease therapy.
    Lou S; Duan Y; Nie H; Cui X; Du J; Yao Y
    Biochimie; 2021 Jun; 185():9-21. PubMed ID: 33711361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem Cell Mimicking Nanoencapsulation for Targeting Arthritis.
    Shin MJ; Park JY; Lee DH; Khang D
    Int J Nanomedicine; 2021; 16():8485-8507. PubMed ID: 35002240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-associated changes in regenerative capabilities of mesenchymal stem cell: impact on chronic wounds repair.
    Yao B; Huang S; Gao D; Xie J; Liu N; Fu X
    Int Wound J; 2016 Dec; 13(6):1252-1259. PubMed ID: 26424496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases.
    Hu C; Wu Z; Li L
    J Cell Mol Med; 2020 Jan; 24(1):40-49. PubMed ID: 31691463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging and Mesenchymal Stem Cells: Therapeutic Opportunities and Challenges in the Older Group.
    Chen H; Liu O; Chen S; Zhou Y
    Gerontology; 2022; 68(3):339-352. PubMed ID: 34161948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying Senescence-Associated Phenotypes in Primary Multipotent Mesenchymal Stromal Cell Cultures.
    Nadeau S; Cheng A; Colmegna I; Rodier F
    Methods Mol Biol; 2019; 2045():93-105. PubMed ID: 31020633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-
    Lee HJ; Kim HD; Jo CH; Bok EY; Kim SB; Lee SL; Jang M; Bae SG; Yun SH; Kim SJ; Rho GJ; Lee WJ
    Biomed Res Int; 2021; 2021():4604856. PubMed ID: 34527737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem/stromal cell function in modulating cell death.
    Naji A; Favier B; Deschaseaux F; Rouas-Freiss N; Eitoku M; Suganuma N
    Stem Cell Res Ther; 2019 Feb; 10(1):56. PubMed ID: 30760307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
    Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
    Front Immunol; 2018; 9():1078. PubMed ID: 29892282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDGF Restores the Defective Phenotype of Adipose-Derived Mesenchymal Stromal Cells from Diabetic Patients.
    Capilla-González V; López-Beas J; Escacena N; Aguilera Y; de la Cuesta A; Ruiz-Salmerón R; Martín F; Hmadcha A; Soria B
    Mol Ther; 2018 Nov; 26(11):2696-2709. PubMed ID: 30195725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in using mesenchymal stromal/stem cells (MSCs) in treating corneal diseases.
    Venkatakrishnan J; Saeed Y; Kao WW
    Ocul Surf; 2022 Oct; 26():255-267. PubMed ID: 36240995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.